CSL Receives Official Warning From FDA

Australia’s largest biotech, CSL, last week received an official warning from the US Food and Drug Administration listing concerns relating to the company’s manufacture of its influenza vaccine, Afluria, at its Parkville, Victoria, plant.
Australian Life Scientist